Erik Przygocki

Erik Przygocki serves as a key procurement professional within the Naval Medical Logistics Command, supporting the Department of Defense’s mission to sustain combat-ready medical forces through strategic acquisition of advanced diagnostic, biotechnological, and life-sustaining medical systems. He manages complex contracting actions for high-priority medical logistics initiatives, including point-of-care diagnostics, clinical research tools, and field-deployable medical equipment. His work directly enables the readiness of Navy and Marine Corps medical units by ensuring timely access to cutting-edge technologies across global operational theaters, with a focus on acquisitions governed by FAR and DFARS compliance. While specific contractor names are not publicly available, Przygocki maintains a broad network of vendors spanning biomedical research firms, clinical testing laboratories, and management consulting services. He engages with both large prime contractors and specialized small businesses to deliver innovative medical solutions, often coordinating multi-year, performance-based contracts that emphasize technical capability, supply chain resilience, and rapid deployment. His contracting patterns reflect a preference for competitive, open solicitations with structured evaluation criteria focused on technical merit and mission alignment. Przygocki’s procurement portfolio is overwhelmingly non-set-aside, with 88.5% of awards issued under full and open competition. However, he consistently incorporates small business participation, with 7.7% of awards designated as total small business set-asides and 3.9% allocated to women-owned small businesses. This balanced approach supports socioeconomic goals without compromising mission-critical requirements, demonstrating a pragmatic commitment to broad vendor participation. His primary technical focus lies in biotechnology research (NAICS 541714) and life sciences R&D (541712), with significant activity in testing laboratories (541380) and management consulting (541611). He procures advanced diagnostic systems, clinical trial support services, and medical logistics optimization tools, reflecting deep expertise in biomedical innovation and operational medical readiness.